Patel Chem Specialities Limited (BOM:544460)

Market Cap	2.18B
Revenue (ttm)	1.16B +41.0%
Net Income	114.70M +49.8%
EPS	5.67 +26.0%
Shares Out	24.87M
PE Ratio	15.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,600
Average Volume	55,280
Open	86.95
Previous Close	86.68
Day's Range	86.15 - 88.95
52-Week Range	56.10 - 120.89
Beta	n/a
RSI	73.40
Earnings Date	Apr 22, 2026

About Patel Chem Specialities

Patel Chem Specialities Limited manufactures and sells cellulose-based excipients. It offers sodium monochloro acetate; BlowTab, a sodium starch glycolate; Disolwell, a croscaremellose sodium; Swellcal, a carboxymethyl cellulose calcium; Rheollose, a sodium carboxymethyl cellulose; and Hindcell, a microcrystalline cellulose. The company also provides PharLub magnesium stearate, AmyloTab C pregelatinized starcg, and sodium chloro acetate. Its products are used in pharmaceutical, textile, agriculture, surfactants and detergents, food and beverage...

• Industry: Chemicals and Allied Products
• Founded: 2008
• Employees: 136
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544460

Financial Performance

In fiscal year 2025, Patel Chem Specialities's revenue was 1.05 billion, an increase of 27.59% compared to the previous year's 823.62 million. Earnings were 105.65 million, an increase of 38.00%.